111 is a China integrated online and offline platform in the healthcare market. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. 111 was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
111 news
16.06.2022
GAAP loss 111 for 3 months of 2022 was CN¥100,988 million, down 40% from CN¥169,483 million in the previous year. Revenue increased 15% to CN¥2.983 billion versus CN¥2.595 billion a year earlier.
Source: ir.111.com.cn
19.11.2021
GAAP loss 111 for 9M 2021 was CN¥519.281 billion, up 57.5% from CN¥329.727 billion in the previous year. Revenue increased 61.2% to CN¥8.965 billion from CN¥5.56 billion a year earlier.
Source: ir.111.com.cn
27.08.2021
GAAP loss 111 for 6M 2021 was CN¥353,501 million, up 61.8% from CN¥218,536 million in the previous year. Revenue increased 75.7% to CN¥5.619 billion versus CN¥3.198 billion a year earlier.
Source: ir.111.com.cn
19.05.2021
GAAP loss of 111 for 3 months of 2021 was ¥169.483 million, an increase of 35.1% compared to ¥125.459 million in the previous year. Revenue increased 64.7% to ¥2.595 billion from ¥1.576 billion a year earlier.
Source: ir.111.com.cn
General information
| Company name | 111 |
|---|---|
| Sector | Consumer Staples / Food & Staples Retailing / Food & Staples Retailing / Drug Retail |
| Business address | No 295 Zu Chongzhi Road Pudong New Area Shanghai, 200120 China |
| Mailing address | No 295 Zu Chongzhi Road Pudong New Area Shanghai, 200120 China |
| Website | ir.111.com.cn |
| Information disclosure | www.sec.gov |
English (US) 